| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |